ArticleVaccines2024

Post-Marketing Surveillance of Adverse Events for the Recombinant Zoster Vaccine Among the Population over 50 Years Old in Hangzhou, China.

Jing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.